Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital

Bulletin Express

Sep 17

On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee Stock Ownership Schemes.

The repurchased shares, acquired at prices ranging from RMB 43.10 to RMB 43.58 per share and averaging RMB 43.29, cost a total of RMB 14.50 million. All 335,000 shares have been classified as treasury stock.

Following the transaction: • Issued shares outstanding (excluding treasury shares) decreased to 6.367 billion from 6.368 billion, a reduction of 0.005%. • Treasury shares rose to 11.77 million from 11.43 million. • The company’s total issued share count remained unchanged at 6.379 billion.

Management confirmed that the repurchase was authorized by the board and complied with all relevant regulations, including the Hong Kong Stock Exchange Main Board Rules and domestic Shanghai Stock Exchange requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1150135700"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150135700\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150135700?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150135700","market":"us","top_or_hot":-1,"title":"Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital","media":"Bulletin Express","content":"<p>On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee Stock Ownership Schemes.</p>\n<p>The repurchased shares, acquired at prices ranging from RMB 43.10 to RMB 43.58 per share and averaging RMB 43.29, cost a total of RMB 14.50 million. All 335,000 shares have been classified as treasury stock.</p>\n<p>Following the transaction:\n• Issued shares outstanding (excluding treasury shares) decreased to 6.367 billion from 6.368 billion, a reduction of 0.005%.  \n• Treasury shares rose to 11.77 million from 11.43 million.  \n• The company’s total issued share count remained unchanged at 6.379 billion.</p>\n<p>Management confirmed that the repurchase was authorized by the board and complied with all relevant regulations, including the Hong Kong Stock Exchange Main Board Rules and domestic Shanghai Stock Exchange requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-17 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee Stock Ownership Schemes.</p>\n<p>The repurchased shares, acquired at prices ranging from RMB 43.10 to RMB 43.58 per share and averaging RMB 43.29, cost a total of RMB 14.50 million. All 335,000 shares have been classified as treasury stock.</p>\n<p>Following the transaction:\n• Issued shares outstanding (excluding treasury shares) decreased to 6.367 billion from 6.368 billion, a reduction of 0.005%.  \n• Treasury shares rose to 11.77 million from 11.43 million.  \n• The company’s total issued share count remained unchanged at 6.379 billion.</p>\n<p>Management confirmed that the repurchase was authorized by the board and complied with all relevant regulations, including the Hong Kong Stock Exchange Main Board Rules and domestic Shanghai Stock Exchange requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1150135700","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150135700","pubTimestamp":1789645419,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药以每股43.29元人民币的价格回购33.5万股A股股票，相当于已发行股本的0.005%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee Stock Ownership Schemes.\nThe repurchased shares, acquired at prices ranging from RMB 43.10 to RMB 43.58 per share and averaging RMB 43.29, cost a total of RMB 14.50 million. All 335,000 shares have been classified as treasury stock.\nFollowing the transaction:\n• Issued shares outstanding (excluding treasury shares) decreased to 6.367 billion from 6.368 billion, a reduction of 0.005%.  \n• Treasury shares rose to 11.77 million from 11.43 million.  \n• The company’s total issued share count remained unchanged at 6.379 billion.\nManagement confirmed that the repurchase was authorized by the board and complied with all relevant regulations, including the Hong Kong Stock Exchange Main Board Rules and domestic Shanghai Stock Exchange requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}